About the Company:
Evoq Remedies Ltd (Company started its operations in the year 2018 onwards)is one of the recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad.
Company procure the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on first-class distribution expertise.
In the healthcare segment, EVOQ being into trading business company offers a wide basket of products.
EVOQ majorly does trading in following segments of pharmaceuticals raw materials:
- Excipients
- Nutraceuticals
- Pellets
- Solvents
- Sweetners
- Vitamins
- Amino Acids
- Bulk Drugs
- Dairy Products
- Active Pharmaceuticals Ingredients.
Company’s Business Model:
Company’s Business Model is bill to ship model. Company procure the pharmaceuticals Raw Materials products and chemicals from the customers which are having WHO-GMP approved production facilities in India and supply to customers as per their requirements.
Company also storage the pharmaceuticals raw material and chemicals at company’s godown and gain the price advantage for stocking such raw material.
Management Team:
- Mr. Bhumishth Narendrabhai Patel (Designation: Chairman Cum Managing Director)
- Mrs. Payal Bhumishth Patel (Designation: Non- Executive and Non-Independent Director)
Objectives of the Issue:
Fresh Issue: (Rs. 9.72 cr )
- To Meet Incremental Working Capital Requirements.
- General Corporate Purpose.
- To meet Public Issue Expenses.
Peer Group Comparison:
There are no listed companies in India whose business portfolio is comparable with that of Evoq Remedies Ltd business and comparable to company’s scale of operations.
Financials of the Company:
(in Crores) | FY 19 | FY 20 | FY 21 | 2nd Oct 2021 |
---|---|---|---|---|
Revenue | 3.25 | 9.07 | 10.02 | 10.56 |
Net Profit | 0.011 | 0.0003 | 0.71 | 0.93 |
IPO Details:
Details | Info |
---|---|
Issue Opens on | 17th March 2022 |
Issue Closes on | 22nd March 2022 |
Issue Price | Rs.27 |
Face Value | Rs.10 |
Minimum Lot | 4000 |
Minimum Investment | Rs.1,08,000 |
Issue Constitutes | 26.47% |
Issue Size | Rs.9.72 cr |
Market Cap | Rs.36.72 cr |
Listing at | BSE SME |
Equity Shares Offered (Fresh) | 36,00,000 (Rs. 9.72 cr) |
Equity Shares Prior to the Issue | 1,00,00,000 |
Equity Shares after the issue | 1,36,00,000 |
Also Read : List of Upcoming IPO’s in India.
Also Read : List of Upcoming SME IPO’s in India.
IPO Valuation Parameters:
Earnings Per Share (EPS) | Price To Earnings ratio (PE) | Return on Net Worth (RoNW) | Net Asset Value (NAV) |
---|---|---|---|
10.05 | 2.69 | 96.94% | 10.37 |
Company Contact Info: |
---|
Evoq Remedies Ltd A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola Ahmedabad -380060, Gujarat. Telephone No: +91 79 4840 2525 E-Mail: info@evoqremedies.com; Website: www.evoqremedies.com; |
IPO Registrar Info: |
---|
Bigshare Services Private Limited Address: 1st Floor, Bharat Tin Works Building, Opp- Vasant Oasis, Makwana Road Marol, Andheri (E), Mumbai-400059, India. Tel. Number: +91 22 62638200 Investors Grievance Id: investor@bigshareonline.com Website: www.bigshareonline.com |
Lead Manager to the Issue: |
---|
SWASTIKA INVESTMART LIMITED SEBI Registration Number: INM000012102 Merchant Banking Division Address: Flat No18 Floor 2 North Wing Madhaveshwar Coop Hsg Society Ltd Madhav Nagar, 11/12 S V Road Andheri W Mumbai Mumbai City- 400058 (Maharashtra). Telephone Number: +91-22-26254568-69 Investors Grievance Id: investorgreivance@swastika.co.in Website: www.swastika.co.in |